東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Alterations in tissue composition an...

Burket, Jayme Carolynn.

FindBook

Google Book

Amazon

博客來

Alterations in tissue composition and nanomechanical properties with ageing, osteoporosis, and treatment.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Alterations in tissue composition and nanomechanical properties with ageing, osteoporosis, and treatment./
作者:	Burket, Jayme Carolynn.
面頁冊數:	176 p.
附註:	Source: Dissertation Abstracts International, Volume: 74-06(E), Section: B.
Contained By:	Dissertation Abstracts International74-06B(E).
標題:	Engineering, Mechanical. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3536762
ISBN:	9781267955449

Alterations in tissue composition and nanomechanical properties with ageing, osteoporosis, and treatment.
Burket, Jayme Carolynn.

Alterations in tissue composition and nanomechanical properties with ageing, osteoporosis, and treatment. - 176 p.

Source: Dissertation Abstracts International, Volume: 74-06(E), Section: B.

Thesis (Ph.D.)--Cornell University, 2013.

Bone mineral density (BMD) is a macro-scale measurement used to diagnose osteoporosis and assess treatment efficacy, but it cannot capture nanoscale alterations within bone microstructures where fracture initiates. The objectives of this research were to determine variations in tissue properties within the microstructures of cortical and cancellous bone with aging, osteoporosis, and treatment, and examine their effects on microcrack resistance and mechanical function at higher length scales.

ISBN: 9781267955449Subjects--Topical Terms:

783786
Engineering, Mechanical.

Alterations in tissue composition and nanomechanical properties with ageing, osteoporosis, and treatment.
LDR:03556nam 2200325 4500 001 1958079
005 20140224122711.5
008 150212s2013 ||||||||||||||||| ||eng d
020 $a 9781267955449
035 $a (MiAaPQ)AAI3536762
035 $a AAI3536762
040 $a MiAaPQ $c MiAaPQ
100 1 $a Burket, Jayme Carolynn. $3 2093057
245 1 0 $a Alterations in tissue composition and nanomechanical properties with ageing, osteoporosis, and treatment.
300 $a 176 p.
500 $a Source: Dissertation Abstracts International, Volume: 74-06(E), Section: B.
500 $a Adviser: Marjolein van der Meulen.
502 $a Thesis (Ph.D.)--Cornell University, 2013.
520 $a Bone mineral density (BMD) is a macro-scale measurement used to diagnose osteoporosis and assess treatment efficacy, but it cannot capture nanoscale alterations within bone microstructures where fracture initiates. The objectives of this research were to determine variations in tissue properties within the microstructures of cortical and cancellous bone with aging, osteoporosis, and treatment, and examine their effects on microcrack resistance and mechanical function at higher length scales.
520 $a First, changes in tissue properties with the natural ageing process were examined in a baboon model for human ageing. Tissue stiffness and hardness followed trends in mineralization and aligned collagen content with animal age, increasing sharply during growth and remaining constant after sexual maturity.
520 $a Once this baseline for the natural ageing process was established, osteoporosis and antiresorptive treatment effects on bone tissue properties were examined in an ovine model for human osteoporosis. Zoledronate, from the most widely prescribed class of osteoporosis drugs (bisphosphonates), was compared with a treatment that acts through endogenous estrogen receptor pathways in bone, raloxifene (a selective estrogen receptor modulator, SERM). zoledronate was most effective in cancellous rather than cortical tissue and provided the greatest increases (relative to osteoporotic tissue) in stiffness, hardness, and mineralization at trabecular surfaces. In comparison, increases in these properties with raloxifene were similar throughout cancellous and cortical tissue. Both treatments improved the estimated bending stiffness of individual trabeculae, possibly providing some explanation for the large reductions in fracture risk with these drugs despite minimal changes in BMD. At higher length scales, zoledronate improved bending stiffness and failure moment in whole bone tests.
520 $a Finally, microcracking resistance was assessed via a newly-developed experimental technique. The reduced resistance to crack elongation in cortical tissue from the osteoporosis model was largely corrected by raloxifene. These results suggest that bisphosphonate/SERM co-treatment treatment could possibly combine the best aspects of both drugs---the rapid improvement in strength with zoledronate and the improved microcrack resistance with raloxifene. The nanoscale alterations in bone tissue documented in this thesis provide a better understanding of normal and pathological bone function and may enable development of improved therapies for the prevention and treatment of osteoporosis.
590 $a School code: 0058.
650 4 $a Engineering, Mechanical. $3 783786
650 4 $a Engineering, Biomedical. $3 1017684
650 4 $a Health Sciences, Aging. $3 1669845
690 $a 0548
690 $a 0541
690 $a 0493
710 2 $a Cornell University. $b Mechanical Engineering. $3 2093058
773 0 $t Dissertation Abstracts International $g 74-06B(E).
790 $a 0058
791 $a Ph.D.
792 $a 2013
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3536762